These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 7820120)

  • 1. Proportionality of protease activities in malignant cells to their metastatic potentials.
    Funahashi T; Shimamura M; Kocha T; Fukuda T; Aoyagi T
    Biol Pharm Bull; 1994 Aug; 17(8):1118-20. PubMed ID: 7820120
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of extracellular alkaline proteases and collagenase induction in Vibrio alginolyticus.
    Hare P; Scott-Burden T; Woods DR
    J Gen Microbiol; 1983 Apr; 129(4):1141-7. PubMed ID: 6310026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Proteases in malignant tumors. Their significance for pathogenesis and possible therapeutic consequences].
    Fröhlich E
    Dtsch Med Wochenschr; 2004 Feb; 129(8):391-5. PubMed ID: 14961448
    [No Abstract]   [Full Text] [Related]  

  • 4. Metastatic NIH 3T3 x LTA cell hybrids express 72 kDa type IV collagenase.
    Xuan JW; Wilson SM; Chin JL; Chambers AF
    Anticancer Res; 1995; 15(4):1227-33. PubMed ID: 7654002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of protease inhibitors on axon growth through astrocytes.
    Fawcett JW; Housden E
    Development; 1990 May; 109(1):59-66. PubMed ID: 2170097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of type IV collagen-degrading metalloproteinases and tissue inhibitors of metalloproteinases in newly established human oral malignant tumor lines.
    Nii M; Kayada Y; Yoshiga K; Takada K; Yanagihara K
    Jpn J Clin Oncol; 1996 Jun; 26(3):117-23. PubMed ID: 8656549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metastasis of C1300 and TBJ murine neuroblastomas correlates with expression of matrix metalloproteinases.
    Fowler C; Zimmer C; Boghaert E; Thomas M; Zimmer S
    Cancer Lett; 1995 Jul; 93(2):171-7. PubMed ID: 7621425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification and characterization of four proteases produced by Streptococcus suis.
    Jobin MC; Grenier D
    FEMS Microbiol Lett; 2003 Mar; 220(1):113-9. PubMed ID: 12644236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteases and protease inhibitors in tumor progression.
    DeClerck YA; Imren S; Montgomery AM; Mueller BM; Reisfeld RA; Laug WE
    Adv Exp Med Biol; 1997; 425():89-97. PubMed ID: 9433492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of inhibitors of plasminogen activator, serine proteinases, and collagenase IV on the invasion of basement membranes by metastatic cells.
    Reich R; Thompson EW; Iwamoto Y; Martin GR; Deason JR; Fuller GC; Miskin R
    Cancer Res; 1988 Jun; 48(12):3307-12. PubMed ID: 2836052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective inhibition of proteolytic enzymes in an in vivo mouse model for experimental metastasis.
    Ostrowski LE; Ahsan A; Suthar BP; Pagast P; Bain DL; Wong C; Patel A; Schultz RM
    Cancer Res; 1986 Aug; 46(8):4121-8. PubMed ID: 3089587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization and determination of the relative abundance of two types of insulin-like growth factor binding protein-5 proteases that are secreted by human fibroblasts.
    Nam TJ; Busby WH; Clemmons DR
    Endocrinology; 1996 Dec; 137(12):5530-6. PubMed ID: 8940380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protease pretreatment increases the efficacy of adenovirus-mediated gene therapy for the treatment of an experimental glioblastoma model.
    Kuriyama N; Kuriyama H; Julin CM; Lamborn KR; Israel MA
    Cancer Res; 2001 Mar; 61(5):1805-9. PubMed ID: 11280727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of matrix metalloproteinase genes in transformed rat cell lines of high and low metastatic potential.
    Sreenath T; Matrisian LM; Stetler-Stevenson W; Gattoni-Celli S; Pozzatti RO
    Cancer Res; 1992 Sep; 52(18):4942-7. PubMed ID: 1325287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of bone resorption by inhibitors of tripeptidyl peptidase-I.
    Vines D; Warburton MJ
    Biochem Soc Trans; 1997 Nov; 25(4):S615. PubMed ID: 9450043
    [No Abstract]   [Full Text] [Related]  

  • 16. New functions of stromal proteases and their inhibitors in tumor progression.
    Noel A; Albert V; Bajou K; Bisson C; Devy L; Frankenne F; Maquoi E; Masson V; Sounni NE; Foidart JM
    Surg Oncol Clin N Am; 2001 Apr; 10(2):417-32, x-xi. PubMed ID: 11382595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chymotrypsin- and trypsin-type serine proteases in rat mast cells: properties and functions.
    Kido H; Fukusen N; Katunuma N
    Arch Biochem Biophys; 1985 Jun; 239(2):436-43. PubMed ID: 3890754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulatory molecules in tumor metastasis.
    Ray S; Chattopadhyay N; Biswas N; Chatterjee A
    J Environ Pathol Toxicol Oncol; 1999; 18(4):251-9. PubMed ID: 15281235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An evaluation of the activation of endogenous pancreatic enzymes during human islet isolations.
    Rose NL; Palcic MM; Shapiro AM; Lakey JR
    Transplant Proc; 2003 Nov; 35(7):2455-7. PubMed ID: 14611984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Representative aminopeptidases and prolyl endopeptidase from murine macrophages: comparative activity levels in resident and elicited cells.
    Olivo Rdo A; Teixeira Cde F; Silveira PF
    Biochem Pharmacol; 2005 May; 69(10):1441-50. PubMed ID: 15857608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.